Besides, many of the so - called abortion drugs are used for cancer and auto -
immune disease treatment, so it is not as simple as just not covering a specific drug.
Not exact matches
The psoriasis field is among the most lucrative (if not the most lucrative) in biopharma, thanks to a combination of a massive patient pool and the ways in which these
treatments can extend to somewhat related
immune and inflammatory conditions, like arthritis and Crohn's
disease.
Today, according to The New York Times, Parker is set to announce that he is donating $ 250 million to bolster the research and development of cancer immunotherapy — a
treatment method that attempts to use cancer patients» own
immune systems to fight the
disease.
Doctors and other health professionals would be
immune from professional conduct charges if they pursued a hotly debated course of
treatment for Lyme
disease under a bill given preliminary approval by the Vermont Senate.
«Steep funding cuts for the federal health agencies are counterproductive at a time when innovative research is moving us closer to identifying solutions for rare
diseases, new prevention strategies to protect Americans from deadly and costly conditions, advances in gene therapy, new technologies for understanding the brain, and
treatments that harness the ability of our
immune system to fight cancer.»
Now, immunotherapy — a type of
treatment that harnesses the patient's
immune system to combat the
disease — represents the future of cancer
treatment, with its efficacy being demonstrated in even the most aggressive types of cancer.
Professor Nutt said increasing our knowledge of the mechanisms that controlled the
immune response was vital for understanding how
immune and inflammatory
diseases arise and, ultimately, developing more effective
treatments.
Understanding how the
immune system works both in health and
disease is crucial if we are to develop new and improved
treatments for inflammatory conditions such as rheumatoid arthritis.»
What's more, the studies suggest how our gut microbes make the
immune system turn against nerve cells — a finding that could lead to
treatments, like drugs based on microbial byproducts, that might improve the course of the
disease.
Specific
immune cells have the ability to produce a healing factor that can promote wound repair in the intestine, a finding that could lead to new, potential therapeutic
treatments for inflammatory bowel
disease (IBD), according to a new research study.
«We believe that some of the classes of contaminants that are now in the environment, such as these endocrine disruptors coming out of sewage
treatment plants, are having an impact on the
immune function in fish and altering
disease resistance,» Winton says.
Researchers targeting colorectal cancer stem cells — the root cause of
disease, resistance to
treatment and relapse — have discovered a mechanism to mimic a virus and potentially trigger an
immune response to fight the cancer like an infection.
«How to reprogram cells in our
immune system: The discovery could improve
treatments for autoimmune
diseases and cancer.»
During the transplant
treatment patients have a compromised
immune system that can not defend the body against
diseases.
By manipulating the function of certain
immune cells, called T cells, researchers could help restore the system's balance and create new
treatments to target these
diseases.
Scientists broke down and rebuilt the
immune systems of mice with
diseases that mimic type 1 diabetes and MS.. The
treatment stopped the progress of diabetes in four out of five mice and put animals with a
disease similar to MS into remission,
With only one drug specifically approved for the
treatment of lupus in the past 50 years, lupus patients are commonly treated with steroids, a class of immunosuppressive drugs that delay the development and progression of the
disease by suppressing the
immune system.
Once they found that the OTULIN gene was abnormal in the sick children, they studied the
immune pathway in order to understand the mechanisms of
disease and to improve
treatment of these patients.
Dr. Alan S. Cross, Professor of Medicine at University of Maryland School of Medicine, who was not involved in the research, shared his input: «This is a major conceptual breakthrough in our understanding of infection and
immune disease mechanisms and may have implications for novel approaches to the
treatment of other
diseases characterized by cytokine storm.
These vulnerable patients, whose
immune defenses have taken a dramatic double hit from both their original
disease and the
treatments required to repopulate their
immune system with donor cells, are especially susceptible to a wide range of infections that typically don't cause major problems in healthy people.
A certain cytokine, or small protein that helps cells communicate during
immune responses, can control whether
immune cells promote or suppress inflammatory bowel
disease, a finding that could lead to new
treatments, according to a study led by Georgia State University.
It is also important to note that HIV research may lead to advances in the
treatment of other viral infections, as well as cancers, metabolic
diseases (diabetes, high cholesterol) and other
immune system disorders.
They also summarise the outcome of clinical trials that have investigated the use of mesenchymal stem cells in the
treatment of a number of inflammatory, degenerative and
immune - mediated
diseases of cats.
But he also believes that medical researchers will overcome some of the thorny obstacles to safe and effective therapies — just as once seemingly insurmountable obstacles to kidney transplants were overcome — clearing the way for
treatment of
diseases such as Parkinson's, blindness, and
immune disorders.
Even autoimmune
diseases, in which the body attacks itself, promise to recede in the face of coming stem cell
treatments as defective
immune cells are replaced with healthy ones.
Monitoring
immune cell activity — including phenotyping
immune cell subsets, tracking cell proliferation, and measuring cytokine production — can provide insights into the overall status of
immune function in patients, particularly those undergoing immunosuppression after transplants, enduring cancer
treatment, or suffering from autoimmune
disease or other pathologies that affect the
immune system.
«And other ongoing research projects have the potential to further expand patients»
treatment options by leveraging other urogenital parasite - derived,
immune - modulating molecules to treat inflammatory bowel
diseases and autoimmune disorders.»
Hot on the heels of discovering a protective form of
immune response to spinal cord injury, researchers at the University of Virginia School of Medicine have pinpointed the biological trigger for that response — a vital step toward being able to harness the body's defenses to improve
treatment for spine injuries, brain trauma, Alzheimer's
disease and other neurodegenerative conditions.
Understanding which cytokines are best for monitoring inflammation and immunosuppression, and knowing which are secreted by different
immune cell types at each stage of maturation and activation, will provide essential insights into
disease treatment options.
Although gene therapy has since proved successful against rare
diseases of the
immune system and shown promise against AIDS (see «Genetic
treatment closes door on HIV»), it has proved much harder to use it to treat CF.
The transplantation of isolated human hematopoietic stem cells is used in the
treatment of anemia,
immune deficiencies and other
diseases, including cancer.
Researchers consider transplants of fetal tissue a promising
treatment for Parkinson's
disease, diabetes and severe disorders of the
immune system.
Researchers hope to use transplanted fetal tissue in
treatments for infant diabetes, Parkinson's
disease, and some severe
immune deficiencies.
«Discovery of brain - like activity in
immune system promises better
disease treatments.»
Current rheumatoid arthritis
treatments focus on intercepting the
immune system's misdirected attack on the lining of affected joints to alleviate the debilitating symptoms, reduce inflammation and slow the progression of the
disease.
Researchers have identified a region of the genome that regulates vitamin D activation in the kidneys, opening the door for more sophisticated
treatments of
diseases, including bone and
immune disorders, involving vitamin D.
The study also measured the antibody
immune response to the bacteria both pre - and post -
treatment, as this is how current diagnostics typically evaluate Lyme
disease in humans.
Overall, this work illustrates that better understanding the basic biology of the
immune system in preclinical models may open up a window for the development of novel
treatments for human autoimmune
disease.
There is no cure for autoimmune
diseases and
treatment generally focuses on reducing the activity of the
immune system.
In developed countries, though, the combination might benefit children and adults whose
immune systems are impaired because of cancer
treatment or
diseases like AIDS and who are vulnerable to rotavirus infections.
- In a study with potentially major implications for the future
treatment of autoimmunity and related conditions, scientists from the Perelman School of Medicine at the University of Pennsylvania have found a way to remove the subset of antibody - making cells that cause an autoimmune
disease, without harming the rest of the
immune system.
Nearly 80 clinical trials have attempted to correct faulty
disease - causing genes, but only
treatments for inherited
immune - deficiency disorders have shown any success.
«Our results suggest that heart failure would be better addressed by
treatments that shut down
immune cells that are both sources and targets of cytokines in the spleen and heart, instead of targeting any one cytokine,» said Sumanth Prabhu, M.D., director of the Division of Cardiovascular
Disease within the UAB School of Medicine and study leader.
Immunotherapy, the use of the
immune system to fight cancer, is revolutionizing
treatment of this
disease, and was selected by the journal Science as the major scientific advance of 2013.
Cancer
treatments that mobilize the body's
immune system to fight the
disease have generated a lot of excitement in the past few years.
These
treatments — used alone or in combination — fight cancer by activating and amplifying the body's
immune response to the
disease.
These are skills that we implement for other international trials of gene therapy for rare genetic
diseases of the
immune system, blood, muscle, vision or liver... We will continue the current study with the objective of providing
treatment for patients.»
«MS
treatment that «resets»
immune system may halt
disease progression for at least 5 years: A type of
treatment for multiple sclerosis that «resets» the
immune system may stop progression of the
disease in nearly half of patients.»
A type of
treatment for multiple sclerosis that «resets» the
immune system may stop progression of the
disease in nearly half of patients.
In the trial, eight patients with severe kidney
disease initially had radiation and drug
treatment to suppress their
immune systems.